Cargando…

Pharmacogenetic Analysis of Pediatric Patients with Acute Lymphoblastic Leukemia: A Possible Association between Survival Rate and ITPA Polymorphism

Genetic polymorphisms are important factors in the effects and toxicity of chemotherapeutics. To analyze the pharmacogenetic and ethnic differences in chemotherapeutics, major genes implicated in the treatment of acute lymphoblastic leukemia (ALL) were analyzed. Eighteen loci of 16 genes in 100 pati...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Hyery, Kang, Hyoung Jin, Kim, Hyo Jeong, Jang, Mi Kyung, Kim, Nam Hee, Oh, Yongtaek, Han, Byoung-Don, Choi, Ji-Yeob, Kim, Chul Woo, Lee, Ji Won, Park, Kyung Duk, Shin, Hee Young, Ahn, Hyo Seop
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3454425/ https://www.ncbi.nlm.nih.gov/pubmed/23029095 http://dx.doi.org/10.1371/journal.pone.0045558

Ejemplares similares

Pharmacogenetic Study of Deferasirox, an Iron Chelating Agent
por: Lee, Ji Won, et al.
Publicado: (2013)

Successful mobilization using a combination of plerixafor and G-CSF in pediatric patients who failed previous chemomobilization with G-CSF alone and possible complications of the treatment
por: Hong, Kyung Taek, et al.
Publicado: (2012)

Treatment outcomes in children with Burkitt lymphoma and L3 acute lymphoblastic leukemia treated using the lymphoma malignancy B protocol at a single institution
por: Park, Eun Sil, et al.
Publicado: (2011)

Chronic graft versus host disease with small bowel obstruction after unrelated hematopoietic stem cell transplantation in a patient with acute myeloid leukemia
por: Yoon, Ju Young, et al.
Publicado: (2012)

Outcome of Reinduction Chemotherapy with a Modified Dose of Idarubicin for Children with Marrow-Relapsed Acute Lymphoblastic Leukemia: Results of the Childhood Acute Lymphoblastic Leukemia (CALL)-0603 Study
por: Koh, Kyung-Nam, et al.
Publicado: (2017)

Successful Treatment of Primary Central Nervous System Lymphoma without Irradiation in Children: Single Center Experience
por: Yoon, Jong Hyung, et al.
Publicado: (2012)

Clinical Outcome of Relapsed or Refractory Burkitt Lymphoma and Mature B-Cell Lymphoblastic Leukemia in Children and Adolescents
por: Kim, Hyery, et al.
Publicado: (2014)

Clinical Characteristics of Pediatric Thalassemia in Korea: A Single Institute Experience
por: Hong, Che Ry, et al.
Publicado: (2013)

Improvement of Induction Remission Rate by Modifying the Dose of Idarubicin for Relapsed Childhood Acute Lymphoblastic Leukemia
por: Yoon, Jong Hyung, et al.
Publicado: (2009)

Double umbilical cord blood transplantation for children and adolescents
por: Kang, Hyoung Jin, et al.
Publicado: (2010)

Targeted busulfan and fludarabine-based conditioning for bone marrow transplantation in chronic granulomatous disease
por: Ju, Hee Young, et al.
Publicado: (2016)

ITPA Polymorphisms and the Incidence of Toxicities in Children with Acute Lymphoblastic Leukemia
por: Svasdisant, Patpetra, et al.
Publicado: (2023)

Hemophagocytic lymphohistiocytosis diagnosed by brain biopsy
por: Ju, Hee Young, et al.
Publicado: (2015)

APEX1 Polymorphism and Mercaptopurine-Related Early Onset Neutropenia in Pediatric Acute Lymphoblastic Leukemia
por: Kim, Hyery, et al.
Publicado: (2018)

Successful Salvage Unrelated Umbilical Cord Blood Transplantation with Two Units After Engraftment Failure with Single Unit in Severe Aplastic Anemia
por: Lee, Ji Won, et al.
Publicado: (2009)

High Transcript Level of FLT3 Associated with High Risk of Relapse in Pediatric Acute Myeloid Leukemia
por: Kang, Hyoung Jin, et al.
Publicado: (2010)

Pharmacometabolomics for predicting variable busulfan exposure in paediatric haematopoietic stem cell transplantation patients
por: Kim, Bora, et al.
Publicado: (2017)

Quantification of Thiopurine Nucleotides in Erythrocytes and Clinical Application to Pediatric Acute Lymphoblastic Leukemia
por: Moon, Soo Young, et al.
Publicado: (2019)

ALK Protein Expression Is Related to Neuroblastoma Aggressiveness But Is Not Independent Prognostic Factor
por: Lee, Ji Won, et al.
Publicado: (2018)

The Effect of NUDT15, TPMT, APEX1, and ITPA Genetic Variations on Mercaptopurine Treatment of Pediatric Acute Lymphoblastic Leukemia
por: Lee, Jae Min, et al.
Publicado: (2021)

Association of systolic blood pressure drop with intravenous administration of itraconazole in children with hemato-oncologic disease
por: Lee, Hyeong Jin, et al.
Publicado: (2015)

Retrospective Analysis of Peripheral Blood Stem Cell Transplantation for the Treatment of High-Risk Neuroblastoma
por: Kim, Eun Kyung, et al.
Publicado: (2007)

Case Report: Mevalonic Aciduria Complicated by Acute Myeloid Leukemia After Hematopoietic Stem Cell Transplantation
por: Kim, Hyery, et al.
Publicado: (2021)

Visual Prognosis of Retinoblastoma in the Posterior Pole Treated with Primary Chemotherapy Plus Local Treatments
por: Kim, Jae Min, et al.
Publicado: (2010)

Prevalence of TPMT and ITPA gene polymorphisms and effect on mercaptopurine dosage in Chilean children with acute lymphoblastic leukemia
por: Farfan, Mauricio J, et al.
Publicado: (2014)

Extra-cranial Malignant Rhabdoid Tumor in Children: A Single Institute Experience
por: Hong, Che Ry, et al.
Publicado: (2015)

Long-term treatment outcomes of children and adolescents with lymphoblastic lymphoma treated with various regimens: a single-center analysis
por: Choi, Ho Jung, et al.
Publicado: (2020)

Clinical Pharmacogenetic Testing and Application: Laboratory Medicine Clinical Practice Guidelines
por: Kim, Sollip, et al.
Publicado: (2017)

Myeloablative treatment supported by autologous stem cell infusion with neuroblastoma.
por: Ryu, Kyung Ha, et al.
Publicado: (2003)

PB1723: CLINICAL AND GENETIC CHARACTERISTICS OF T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA WITH STIL-TAL1 FUSION
por: Chang, Soon Hee, et al.
Publicado: (2023)

Platelet count recovery after intravenous immunoglobulin predicts a favorable outcome in children with immune thrombocytopenia
por: Choi, Hyoung Soo, et al.
Publicado: (2016)

Effect of ITPA Polymorphism on Adverse Drug Reactions of 6-Mercaptopurine in Pediatric Patients with Acute Lymphoblastic Leukemia: A Systematic Review and Meta-Analysis
por: Lee, Yeonhong, et al.
Publicado: (2022)

P404: IMMUNOGLOBULIN GENE REARRANGEMENT IN KOREAN PATIENTS WITH B-LYMPHOBLASTIC LEUKEMIA – AN IMMUNOPHENOTYPE AND REPERTOIRE ANALYSIS
por: Chu, Daehyun, et al.
Publicado: (2023)

Association of ITPA Genotype with Event-Free Survival and Relapse Rates in Children with Acute Lymphoblastic Leukemia Undergoing Maintenance Therapy
por: Smid, Alenka, et al.
Publicado: (2014)

Pharmacogenetics of asparaginase in acute lymphoblastic leukemia
por: Abaji, Rachid, et al.
Publicado: (2019)

Unrelated Bone Marrow Transplantation with a Reduced Toxicity Myeloablative Conditioning Regimen in Wiskott-Aldrich Syndrome
por: Kang, Hyoung Jin, et al.
Publicado: (2008)

The rs1127354 Polymorphism in ITPA Is Associated with Susceptibility to Infertility
por: Mollaahmadi, Fahimeh, et al.
Publicado: (2018)

ITPA Related Developmental Encephalopathy: Key Role of Neuroimaging
por: Çavuşoğlu, Dilek, et al.
Publicado: (2022)

Optimal predictor for 6-mercaptopurine intolerance in Chinese children with acute lymphoblastic leukemia: NUDT15, TPMT, or ITPA genetic variants?
por: Zhou, Hong, et al.
Publicado: (2018)

ITPA, TPMT, and NUDT15 Genetic Polymorphisms Predict 6-Mercaptopurine Toxicity in Middle Eastern Children With Acute Lymphoblastic Leukemia
por: Moradveisi, Borhan, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_dd6jt1dfgjbt2jhgnf5g6tcc7g